ABSTRACT
Diastole is the sequence of physiological events that occur in the heart during ventricular filling and principally depends on myocardial relaxation and chamber stiffness. Abnormal diastolic function is related to many cardiovascular disease processes and is predictive of health outcomes, but its genetic architecture is largely unknown. Here, we use machine learning cardiac motion analysis to measure diastolic functional traits in 39,559 participants of UK Biobank and perform a genome-wide association study. We identified 9 significant, independent loci near genes that are associated with maintaining sarcomeric function under biomechanical stress and genes implicated in the development of cardiomyopathy. Age, sex and diabetes were independent predictors of diastolic function and we found a causal relationship between ventricular stiffness and heart failure. Our results provide novel insights into the genetic and environmental factors influencing diastolic function that are relevant for identifying causal relationships and tractable targets in heart failure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by Bayer AG; Medical Research Council (MC-A658-5QEB0); National Institute for Health Re-search (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation (NH/17/1/32725, RG/19/6/34387,RE/18/4/34215); Wellcome Trust (107469/Z/15/Z); Academy of Medical Sciences (SGL015/1006); Mason Medical Research Trust grant; and the Engineering and Physical Sciences Research Council (EP/P001009/1). H.V.M. also receives funding from the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All subjects provided written informed consent for participation in the study, which was also approved by the National Research Ethics Service (11/NW/0382). A statement on research ethics approval for this biobank is available online (https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics). Our study was conducted under terms of access approval number 28807 and 40616.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* These authors jointly supervised this work
Data Availability
All raw and derived data in this study is available from UK Biobank (http://www.ukbiobank.ac.uk/). GWAS summary level data are publicly available through the GWAS catalogue.
